Compare SMX Security Matters plc (SMX) vs Tango Therapeutics Inc. (TNGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SMX Security Matters plc vs Tango Therapeutics Inc. — how do they compare? SMX Security Matters plc trades at $3.88 (market cap $4.09M), while Tango Therapeutics Inc. trades at $22.23 (market cap $3.75B). The key difference: Tango Therapeutics Inc. is far larger — about 916.9× SMX Security Matters plc's market cap, and Tango Therapeutics Inc. is trading nearer its 52-week high, SMX Security Matters plc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SMX Security Matters plc for 22 Days and Tango Therapeutics Inc. for 0 Days on average.
| SMX | TNGX | |
|---|---|---|
Market Cap | $4.09M | $3.75B |
Volume | 108,612 | 9,619,106 |
Sector | Industrials | Health |
52-Week High | $74.08K | $32.90 |
52-Week Low | $3.56 | $7.50 |
Typical Hold Time | 22 Days | 0 Days |
Enterprise Value | -$27.23M | $2.77B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SMX stock trades at $3.79, up 4.7% today, but faces severe fundamental challenges with no revenue reported for 2025 and a net loss of $169.18 million. The technical outlook is bearish based on moving averages, though oversold oscillators suggest potential for a near-term bounce. The company is actively promoting its Digital Material Passport technology for recycling and material verification, generating significant media coverage in outlets like Forbes and TIME as of late September 2026.
The investment case is highly speculative. While the company's technology narrative is gaining media traction, the absence of revenue and deeply negative profitability metrics present substantial risk. Investor optimism appears driven by the long-term potential of its circular economy platform rather than current financial performance, making the stock suitable only for risk-tolerant investors betting on a successful business turnaround.
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →
